TAO Synergies (TAOX) Research Hub

TAO Synergies (TAOX) trades on NASDAQ, US in the Technology (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.19 USD (-3.63%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.27, market cap 0.01B. This hub links to the full technical, earnings and options research available for TAOX.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorTechnology (Biotechnology)
ExchangeNASDAQ, US
Last close3.19 USD (-3.63%)
52-week range3.07 USD – 5.35 USD
Trend regimeRange
14-day RSI20 (Oversold)
Trailing P/E-0.27
Market cap0.01B
Dividend yield0.00%
Next earnings2026-08-07

Available research for TAOX

Earnings

TAOX earnings date and last-quarter result: next report 2026-08-07, P/E -0.27. Updated 2026-07-23.

Options: Covered Call

Covered Call on TAOX: how it works, illustrative setup around the real 3.19 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on TAOX: how it works, illustrative setup around the real 3.19 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on TAOX: how it works, illustrative setup around the real 3.19 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

TAOX technical analysis: range, last 3.19 USD, RSI 20, 52w range 3.07 USD–5.35 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is TAOX in?

TAO Synergies (TAOX) is classified under Technology (Biotechnology), listed on NASDAQ, US.

Is TAOX in an uptrend or downtrend?

As of 2026-10-26, TAOX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is TAOX's trailing P/E ratio?

TAOX's trailing P/E is -0.27, with a market cap of 0.01B. See the earnings research page for full valuation detail.

When does TAOX next report earnings?

TAOX is next scheduled to report earnings on 2026-08-07.